Other
Restructuring, Settlement and Impairment Provisions
Edwards Lifesciences Restructuring, Settlement and Impairment Provisions decreased by 100.0% to $0 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $4.2M to $0.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2022
Last reportedQ1 2026May 6, 2026
Metric ID:
other_restructuring_settlement_and_impairment_provisionsHistorical Data
13 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.18M | $15.18M | $15.18M | $15.18M | $0 | $0 | $0 | $0 | $0 | $0 | $4.2M | $4.2M | $0 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — | — | — | — | +0.0% | -100.0% |
| YoY Change | — | — | — | — | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — | — | -100.0% |
Range$0 – $15.18M
CAGR-100.0%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Frequently Asked Questions
- What is Edwards Lifesciences's restructuring, settlement and impairment provisions?
- Edwards Lifesciences (EW) reported restructuring, settlement and impairment provisions of $0 in Q1 2026.
- How has Edwards Lifesciences's restructuring, settlement and impairment provisions changed year-over-year?
- Edwards Lifesciences's restructuring, settlement and impairment provisions decreased by 100.0% year-over-year, from $4.2M to $0.